Frank A Giordano
Overview
Explore the profile of Frank A Giordano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
134
Citations
1322
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schneider M, Potthoff A, Ahmadipour Y, Borger V, Clusmann H, Combs S, et al.
BMC Cancer
. 2025 Feb;
25(1):306.
PMID: 39979825
Background: The discovery of cellular tumor networks in glioblastoma, with routes of malignant communication extending far beyond the detectable tumor margins, has highlighted the potential of supramarginal resection strategies. Retrospective...
2.
Xie J, Bicu A, Grehn M, Kuru M, Zaman A, Lu X, et al.
Phys Imaging Radiat Oncol
. 2025 Feb;
33:100700.
PMID: 39911878
Background And Purpose: Motion management strategies such as gating under breath-hold can reduce breathing-induced motion during stereotactic arrhythmia radioablation (STAR) for refractory ventricular tachycardia. However, heartbeat-induced motion is essential to...
3.
Ruder A, Mohamed S, Hoesl M, Neumaier-Probst E, Giordano F, Schad L, et al.
PLoS One
. 2024 Nov;
19(11):e0313199.
PMID: 39495788
Background: Stereotactic radiosurgery (SRS) is an effective therapy for brain metastases. Response is assessed with serial 1H magnetic resonance imaging (MRI). Early markers for response are desirable to allow for...
4.
Hohmann S, Xie J, Eckl M, Grehn M, Karfoul N, Janorschke C, et al.
Radiother Oncol
. 2024 Sep;
200:110499.
PMID: 39242029
Background: Stereotactic arrhythmia radioablation (STAR) is a therapeutic option for ventricular tachycardia (VT) where catheter-based ablation is not feasible or has previously failed. Target definition and its transfer from electro-anatomic...
5.
Aumuller P, Rothfuss A, Polednik M, Abo-Madyan Y, Ehmann M, Giordano F, et al.
Z Med Phys
. 2024 Sep;
35(1):112.
PMID: 39227220
No abstract available.
6.
Sarria G, Fleckenstein J, Eckl M, Stieler F, Ruder A, Bendszus M, et al.
Invest Radiol
. 2024 Aug;
60(2):138-144.
PMID: 39159365
Purpose: The aim of this study was to assess the effect of gadopiclenol versus gadobenate dimeglumine contrast-enhanced magnetic resonance imaging (MRI) on decision-making between whole-brain radiotherapy (WBRT) and stereotactic radiosurgery...
7.
Giordano F, Layer J, Leonardelli S, Friker L, Turiello R, Corvino D, et al.
Nat Commun
. 2024 May;
15(1):4210.
PMID: 38806504
The chemokine CXCL12 promotes glioblastoma (GBM) recurrence after radiotherapy (RT) by facilitating vasculogenesis. Here we report outcomes of the dose-escalation part of GLORIA (NCT04121455), a phase I/II trial combining RT...
8.
Buttner T, Maerevoet M, Giordano F, Veldwijk M, Herskind C, Ruder A
Radiat Oncol
. 2024 Jan;
19(1):16.
PMID: 38291439
Background: Ionotropic glutamate receptors α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor (AMPAR) and N-methyl-D-aspartate receptor (NMDAR) modulate proliferation, invasion and radioresistance in glioblastoma (GB). Pharmacological targeting is difficult as many in vitro-effective agents...
9.
Layer J, Shiban E, Brehmer S, Diehl C, Guedes de Castro D, Hamed M, et al.
Int J Radiat Oncol Biol Phys
. 2024 Jan;
118(5):1552-1562.
PMID: 38199383
Purpose: After surgical resection of brain metastases (BMs), intraoperative radiation therapy (IORT) provides a promising alternative to adjuvant external beam radiation therapy by enabling superior organ-at-risk preservation, reduction of in-hospital...
10.
Spaniol M, Abo-Madyan Y, Ruder A, Fleckenstein J, Giordano F, Stieler F
Phys Med
. 2023 Dec;
117:103202.
PMID: 38159546
Purpose: Stereotactic radiosurgery with linear accelerators (LINACs) or Leksell Gamma Knife® (LGK, Elekta AB) is an established treatment option for intracranial tumors. When those are involving/abutting organs at risk (OAR),...